ClinVar Miner

Submissions for variant NM_203446.3(SYNJ1):c.1744A>G (p.Thr582Ala)

gnomAD frequency: 0.00004  dbSNP: rs370817503
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001996697 SCV002227163 uncertain significance Early-onset Parkinson disease 20; Developmental and epileptic encephalopathy, 53 2022-10-24 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 621 of the SYNJ1 protein (p.Thr621Ala). This variant is present in population databases (rs370817503, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with SYNJ1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1447060). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SYNJ1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002563484 SCV003583708 uncertain significance Inborn genetic diseases 2021-09-15 criteria provided, single submitter clinical testing The c.1861A>G (p.T621A) alteration is located in exon 15 (coding exon 15) of the SYNJ1 gene. This alteration results from a A to G substitution at nucleotide position 1861, causing the threonine (T) at amino acid position 621 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003120770 SCV003800949 uncertain significance not specified 2023-01-12 criteria provided, single submitter clinical testing Variant summary: SYNJ1 c.1861A>G (p.Thr621Ala) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250274 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1861A>G in individuals affected with SYNJ1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. One submitter has provided a clinical-significance assessment for this variant to ClinVar after 2014, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.